Phase 2 Plasmodium Falciparum Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 2
Safety and Efficacy of Imatinib in Combination With Artemether-Lumefantrine for Uncomplicated Malaria
Malaria (Plasmodium Falciparum)
Victoria Biomedical Research Institute1,116 enrolled1 locationNCT07559370
Recruiting
Phase 2
Dose Finding Trial of R21/Matrix-M in School Children
Malaria (Plasmodium Falciparum)
University of Oxford40 enrolled1 locationNCT07074665
Recruiting
Phase 2
Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Patients With Uncomplicated Plasmodium Falciparum Malaria
Uncomplicated Plasmodium falciparum malaria
Novartis Pharmaceuticals327 enrolled12 locationsNCT05750628
Terminated
Phase 2Phase 3
Monitoring and evaluation of the efficacy and safety of Artesunate-Mefloquine (ASMQ) and Artesunate-Pyronaridine (ASP) for the treatment of uncomplicated Plasmodium falciparum and Plasmodium vivax malaria in Cambodia
Patients with Plasmodium falciparum infectionPatients with Plasmodium vivax infection
Ministry of Health120 enrolled1 locationACTRN12622000638730